Back
BioGaia AB 10K Form
Sell
3
BGLAF
BioGaia AB
Last Price:
9.58
Seasonality Move:
-2.64%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive BGLAF News And Ratings
See the #1 stock for the next 7 days that we like better than BGLAF
BGLAF Financial Statistics
Sales & Book Value
| Annual Sales: | $122.46M |
|---|---|
| Cash Flow: | $9.79M |
| Price / Cash Flow: | 27.3 |
| Annual Sales: | $1.59 |
| Price / Book: | 6.03 |
Profitability
| EPS (TTM): | 0.31760 |
|---|---|
| Net Income (TTM): | $32.03M |
| Gross Margin: | $89.75M |
| Return on Equity: | 17.87% |
| Return on Assets: | 15.34% |
BioGaia AB Earnings Forecast
Key BioGaia AB Financial Ratios
- The Gross Profit Margin over the past 22 years for BGLAF is 73.29%.
- The Selling, General & Administrative Expenses for BGLAF have been equal to 31.05% of Gross Profit Margin.
- The Research & Development expenses have been 8.24% of Revenue.
- The Interest Expense is 0.22% of Operating Income.
- The Net Earning history of BGLAF is 28.18% of Total Revenues.
- Per Share Earnings over the last 22 years have been positive in 12 years.
BioGaia AB Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | OTCM |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | BGLAF |
| Website: | biogaia.se |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 7.78 |
| Quick Ratio: | 5.79 |
Price-to-Earnings
| Trailing P/E Ratio: | 28.02 |
|---|---|
| Forward P/E Ratio: | 0 |
BGLAF Technical Analysis vs Fundamental Analysis
Sell
3
BioGaia AB (BGLAF)
is a Sell
Is BioGaia AB a Buy or a Sell?
-
BioGaia AB stock is rated a Sell
The current BioGaia AB [BGLAF] share price is $9.58. The Score for BGLAF is 3, which is 94% below its historic median score of 50, and infers higher risk than normal.